Rosen Law Firm Announces Investigation of Securities Claims Against Henry Schein, Inc.
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of purchasers of the securities of Henry Schein, Inc. (NASDAQ: HSIC) resulting from allegations that Henry Schein may have issued materially misleading business information to the investing public.
On February 12, 2018, the Federal Trade Commission (“FTC”) announced that it filed a complaint against the nation’s three largest dental supply companies — Henry Schein, Benco Dental Supply Company, and Patterson Companies, Inc. — alleging they violated U.S. antitrust laws by conspiring to refuse to provide discounts to or otherwise serve buying groups representing dental practitioners. According to this announcement, the complaint details communications between executives of Benco and Henry Schein evidencing the agreement, and their attempts to monitor and ensure compliance with the agreement. The FTC also alleges that Patterson joined the agreement. On this news, shares of Henry Schein fell sharply during intraday trading on February 13, 2018.
Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Henry Schein investors. If you purchased shares of Henry Schein, please visit the firm’s website at http://www.rosenlegal.com/cases-1291.html for more information. You may also contact Phillip Kim or Daniel Sadeh of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.